Skip to main content

Donato Leslie E's Form 4/A amendment

Amended

Keenova Therapeutics plc (MNKTQ) · filed Jul 17, 2026

Accession no.
0001104659-26-084773
Filed
Jul 17, 2026, 9:54 PM ET
Trade date
Jun 2, 2026
Filing delay
45 days
Rule 10b5-1 plan
Not checked
Original filed
Jun 4, 2026

This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 45 days after the trade.

This amendment replaces 0001104659-26-070521 (filed Jun 4, 2026).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Donato Leslie ECIK 0001784795Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 2, 2026Ordinary SharesMOption exerciseAcquired+2,685––2,685Direct
Jun 2, 2026Ordinary SharesFTax withholdingDisposed−619––2,066Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 2, 2026Ordinary SharesDReturned to the companyDisposed−2,197––6,669Direct
Jun 2, 2026Ordinary SharesMOption exerciseDisposed−2,685$0.00$03,984Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)